Fletcher Ws
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 3
- Colorectal Cancer Treatments and Studies 3
- Dermatology top 10%
-
- Sarcoma Diagnosis and Treatment 2
-
- Neuroendocrine Tumor Research Advances 5
-
- Radiopharmaceutical Chemistry and Applications 4
-
- Estrogen and related hormone effects 4
-
- HIV/AIDS drug development and treatment 2
-
- Cancer Research and Treatments 2
- Co-authors
- Metter GeGrage TbWeiss AjPing Yein LeeKenneth R. StevensMichelle HarrisonTruman M. SasakiKrementz Et
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (37 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Fletcher Ws
33 papers receiving 452 citations
Peers
Comparison fields: 5 of 71
- Oncology 297
- Pathology and Forensic Medicine 103
- Cardiology and Cardiovascular Medicine 116
- Dermatology 41
- Pulmonary and Respiratory Medicine 134
Countries citing papers authored by Fletcher Ws
This map shows the geographic impact of Fletcher Ws's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fletcher Ws with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fletcher Ws more than expected).
Fields of papers citing papers by Fletcher Ws
This network shows the impact of papers produced by Fletcher Ws. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fletcher Ws. The network helps show where Fletcher Ws may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fletcher Ws, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Suppression of primary and secondary peptides with somatostatin analog in the therapy of functional endocrine tumors. | 1988 | 7 |
| 2 | Phase II evaluation of spirogermanium in malignant melanoma: a Southwest Oncology Group Study. | 1987 | 1 |
| 3 | Analysis of the risk reduction of prophylactic partial mastectomy in Sprague-Dawley rats with 7,12-dimethylbenzanthracene-induced breast cancer. | 1986 | 20 |
| 4 | Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: a Southwest Oncology Group Study. | 1985 | 2 |
| 5 | Endocrine ablation and hepatic artery infusion in the treatment of metastases to the liver from carcinoma of the breast. | 1982 | 7 |
| 6 | Superior vena caval thrombosis as a complication of peritoneovenous shunt in malignancy. | 1981 | 3 |
| 7 | DTIC and combination therapy for melanoma. II. Escalating schedules of DTIC with BCNU, CCNU, and vincristine. | 1980 | 19 |
| 8 | Phase II study of 5-azacytidine in solid tumors. | 1977 | 38 |
| 9 | Islet cell carcinoma of the pancreas: effective therapy with 5-fluorouracil, streptozotocin, and tubercidin. | 1976 | 6 |
| 10 | DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065). | 1976 | 28 |
| 11 | Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.? | 1976 | 6 |
| 12 | Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. | 1976 | 110 |
| 13 | Therapeutic value of nafoxidine hydrochloride in the treatment of advanced carcinoma of the human breast. | 1976 | 3 |
| 14 | The importance of the canine species in biomedical research. | 1975 | 0 |
| 15 | Management of chylothorax secondary to lymphoma. | 1972 | 11 |
| 16 | Search for new cancer drugs: streptozotocin. | 1972 | 2 |
| 17 | Mesh wrapping in the treatment of abdominal aortic aneurysms: a preliminary report. | 1968 | 2 |
| 18 | Severe tumor pain with intravenous injection of vinblastine sulfate (NSC-49842). | 1966 | 1 |
| 19 | ENHANCEMENT OF THE THERAPEUTIC EFFECT OF STILBESTEROL ON EXPERIMENTAL BREAST CANCER. | 1963 | 1 |
| 20 | A CLINICAL STUDY OF PRIMARY CARCINOMA OF THE GALLBLADDER. | 1963 | 18 |
About Fletcher Ws
Fletcher Ws is a scholar working on Equine, Oncology, Radiology, Nuclear Medicine and Imaging, Biotechnology and Genetics, having authored 38 papers that have together received 518 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Estrogen and related hormone effects (4 papers), Pancreatic and Hepatic Oncology Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), HIV/AIDS drug development and treatment (2 papers), Cancer Research and Treatments (2 papers) and Sarcoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (297 citations), Pathology and Forensic Medicine (103 citations), Cardiology and Cardiovascular Medicine (116 citations), Dermatology (41 citations) and Pulmonary and Respiratory Medicine (134 citations). Fletcher Ws has collaborated with scholars based in United States and Canada. Frequent co-authors include Metter Ge, Grage Tb, Weiss Aj, Ping Yein Lee, Kenneth R. Stevens, Michelle Harrison, Truman M. Sasaki, Krementz Et, Nealon Tf and Minton Jp. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.